Products

Hyfe
Hyfe
Drug Discovery & Research
Hyfe offers an advanced acoustic AI system for detecting and monitoring cough, establishing it as a routinely measured biomarker and endpoint for clinical research and respiratory care.

See all 1 product →

About Hyfe

Hyfe is a digital health company that specializes in AI-powered cough detection, tracking, and classification. The company’s core technology utilizes acoustic artificial intelligence to passively and continuously monitor cough frequency and patterns in real-world settings. This on-device AI processing ensures patient privacy by detecting coughs locally and only transmitting metadata (timestamps) rather than recording or storing audio.

For physicians, Hyfe offers a validated platform to gain objective, continuous, and longitudinal cough data, which has historically been difficult to measure reliably. This data can be used as an endpoint in clinical trials for drug and device development, enabling more sensitive detection of treatment effects and advancing respiratory research beyond subjective patient reports. Hyfe’s technology is also designed to empower healthcare providers to optimize patient care and support digital therapeutics for managing respiratory illnesses, including chronic cough. The company has partnerships with leading academic institutions like Johns Hopkins University and the University of California at San Francisco, and its technology has been used in over 50 clinical studies.

Focus Areas

Respiratory health AI digital health cough detection remote patient monitoring clinical trials disease management

Business Intelligence

TechnologyCloud-native AI platform, edge computing capabilities for real-time sound analysis, proprietary cough detection algorithms

What Physicians Need to Know

Specialization
Hyfe specializes in AI-powered, continuous cough detection and monitoring to provide objective, quantitative data on cough frequency and patterns in real-world settings. They are a digital biomarker and digital endpoint company focused on respiratory health.
Key Differentiators
Hyfe's AI models operate continuously in real-world environments, not just curated recordings. Their technology is privacy-preserving, with on-device processing that detects cough events and outputs non-identifiable metadata (like timestamps and counts) without recording or storing raw audio. They offer regulator-grade measurement, built for clinical trials and research, providing objective data that moves beyond subjective patient reports.
Technology Stack
Hyfe utilizes machine-learning acoustic models trained on extensive, diverse, and real-world datasets of cough and non-cough acoustic events. Their AI runs on-device (edge computing) on various hardware, including smartphones and wearables, ensuring privacy and continuous monitoring. They leverage tools like Edge Impulse for developing and optimizing their neural cough classifier models, which use Mel-Filterbank Energies (MFEs) for acoustic representation.
Applications
Their technology is used in clinical trials for respiratory and cough-related conditions, by pharmaceutical companies, CROs, academic researchers, and digital health partners. Hyfe also offers a digital therapeutic (DTx) called ResolveDTx for chronic cough, combining continuous monitoring with behavioral cough suppression therapy.
Physician Tip

For physicians, Hyfe offers a significant advancement by providing objective, continuous, and quantitative cough data, moving beyond unreliable subjective patient reports. This data can improve diagnostics, disease management, and treatment efficacy assessment for conditions where cough is a key symptom, such as chronic cough, COPD, asthma, and congestive heart failure. The privacy-preserving nature of their on-device AI ensures patient comfort and regulatory compliance, making it a practical tool for long-term monitoring in both clinical and remote settings. The ability to integrate with telehealth platforms and provide real-time insights can lead to more personalized treatment plans and enhanced patient care.

Hyfe's structured, time-stamped outputs can be integrated into Electronic Data Capture (EDC) systems, aligned with eCOA timestamps, or incorporated into centralized data repositories. They support various integration models, including direct monitoring as a service, licensed deployment within clinical trials, strategic partnerships for broader therapeutic strategies, and embedding within third-party digital health or wearable platforms. Notable partnerships include integration with ObvioHealth's decentralized clinical trials platform and ActiGraph's FDA-cleared LEAP wearable for clinical research. They also partner with pharmaceutical companies like Merck for consumer disease education efforts.

Products by Hyfe

1 product in the directory

Hyfe
Hyfe
Drug Discovery & Research
Hyfe offers an advanced acoustic AI system for detecting and monitoring cough, establishing it as a routinely measured biomarker and endpoint for clinical research and respiratory care.

Videos

News, demos, and interviews about Hyfe.

Loading videos...

Videos load interactively. If none appear, search YouTube for Hyfe →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Hyfe is a company that utilizes AI to detect and analyze coughs, providing insights into respiratory health. Their technology uses machine learning algorithms to identify and classify cough sounds, differentiating them from other noises and tracking patterns over time. This data can then be used to monitor disease progression, assess treatment efficacy, and potentially identify early signs of respiratory issues.
Hyfe's technology can be integrated into RPM programs by providing a continuous and objective measure of cough frequency and characteristics, which are crucial digital biomarkers for many respiratory conditions. This data can be seamlessly incorporated into existing patient monitoring platforms, allowing healthcare providers to remotely track patient progress, identify exacerbations sooner, and personalize care plans for chronic respiratory diseases like asthma, COPD, and CHF.
Hyfe's technology is backed by extensive research and clinical validation, demonstrating high accuracy in cough detection and characterization. Their algorithms have been trained on vast datasets of real-world cough sounds, and studies have shown its effectiveness in various clinical settings. This evidence supports its utility as a reliable tool for objective cough assessment, aiding in diagnosis, treatment monitoring, and research.
Hyfe offers flexible pricing models tailored to the needs of individual healthcare organizations, which can include per-patient fees, subscription models, or enterprise-level agreements. They provide comprehensive technical support, including integration assistance, ongoing maintenance, and dedicated account management. Additionally, Hyfe offers training programs for healthcare professionals to ensure effective implementation and utilization of their technology within clinical workflows.
Hyfe has established partnerships with leading academic institutions, pharmaceutical companies, and healthcare providers to further validate and integrate its technology. The company demonstrates strong financial backing and a clear vision for advancing AI in respiratory health, aiming to become a cornerstone in the management of cough-related conditions. Their long-term strategy focuses on expanding their digital biomarker capabilities and improving patient outcomes through continuous innovation.

Investors

Who's funded Hyfe.

Related Companies

Cymetica Biosciences, operating under the brand Biomiv, develops AI systems to create proprietary algorithms aimed at optimizing human health outcomes in real-time. Their work is rooted in research from human space flight, also known as ‘space biosciences,’ and biological language modeling. The company’s AI models construct proprietary vector embeddings to fine-tune AI, enabling the extraction […]

Vitestro is a company dedicated to redefining diagnostic blood collection through automation. Their flagship product, Aletta®, is the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). Aletta automates the entire diagnostic blood collection process, aiming to set a new standard for efficiency and consistency in phlebotomy. The company addresses global challenges in manual phlebotomy, such as […]

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

NeuraMetrix is a Software as a Medical Device (SaMD) company that has developed a novel and highly accurate digital biomarker for detecting and monitoring neurological diseases and psychiatric disorders. Their core technology, NeuraMetrix Typing Cadence (TC), passively and continuously measures typing inconsistency to assess brain health. The NeuraMetrix Typing Cadence (TC) biomarker aims to provide […]

ClinicalTrials.gov is a publicly accessible website and online database of clinical research studies, managed by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). It serves as a central resource for patients, their families, healthcare professionals, and researchers to access comprehensive information on publicly and privately supported clinical studies across a […]

VitalTech offers a comprehensive enterprise solution for virtual care coordination, designed to integrate seamlessly into existing healthcare workflows. The platform provides real-time actionable insights from patient data, aiming to improve patient outcomes, care quality, and safety. It is built with a flexible and agile technology stack, incorporating AI and machine learning capabilities from its foundational […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.